Position in URGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,418,481
-$1,710,983 QoQ
Shares Held
523,831
+10.2% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. URGN ranks #166 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in URGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,418,481 | 523,831 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,129,464 | 475,212 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $9,401,017 | 471,229 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $6,448,946 | 470,726 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,235,029 | 473,330 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,919,255 | 461,902 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $5,786,589 | 455,637 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,070,907 | 421,389 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $4,859,280 | 323,952 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,687,740 | 312,516 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,069,969 | 219,127 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,087,812 | 201,721 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $132,834 | 14,376 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $127,515 | 14,376 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $119,608 | 14,376 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $117,739 | 14,376 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,534,815 | 176,213 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,595,369 | 167,757 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,593,391 | 154,185 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,528,635 | 165,595 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,217,414 | 165,165 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,642,488 | 146,642 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,866,590 | 148,605 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,889,712 | 148,917 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,454,516 | 137,585 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||